Mason Carrico
Stock Analyst at Stephens
(0.67)
# 4,204
Out of 4,668 analysts
56
Total ratings
37%
Success rate
-4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Rated: Hold | $30 → $3 | $3.22 | -6.83% | 6 | Aug 18, 2026 | |
| VCYT Veracyte | Maintained: Buy | $32 → $55 | $41.79 | +31.61% | 5 | Aug 4, 2026 | |
| GH Guardant Health | Maintained: Buy | $63 → $195 | $167.88 | +16.15% | 4 | Aug 4, 2026 | |
| ATEC Alphatec Holdings | Initiated Coverage: Buy | $15 | $9.29 | +61.46% | 1 | Jul 23, 2026 | |
| IRTC iRhythm Holdings | Initiated Coverage: Buy | $160 | $127.98 | +25.02% | 1 | Jul 22, 2026 | |
| CTKB Cytek Biosciences | Rated: Buy | $4 → $4.75 | $4.66 | +1.93% | 3 | May 13, 2026 | |
| ESTA Establishment Labs Holdings | Rated: Buy | $90 | $71.52 | +25.84% | 1 | Feb 25, 2026 | |
| GKOS Glaukos | Maintained: Buy | $115 → $145 | $184.89 | -21.57% | 2 | Jan 2, 2026 | |
| PACB Pacific Biosciences of California | Maintained: Buy | $2.5 → $2 | $1.23 | +62.60% | 3 | Nov 10, 2025 | |
| NEO NeoGenomics | Maintained: Buy | $18 → $11 | $16.53 | -33.45% | 4 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $156 → $110 | $213.24 | n/a | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $70 | $20.73 | n/a | 1 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $18 | $46.99 | n/a | 7 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $63.87 | n/a | 3 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $32.93 | n/a | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $324.84 | n/a | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.1 → $1.25 | $4.30 | n/a | 2 | May 24, 2022 |
Myriad Genetics
Aug 18, 2026
Rated: Hold
Price Target: $30 → $3
Current: $3.22
Upside: -6.83%
Veracyte
Aug 4, 2026
Maintained: Buy
Price Target: $32 → $55
Current: $41.79
Upside: +31.61%
Guardant Health
Aug 4, 2026
Maintained: Buy
Price Target: $63 → $195
Current: $167.88
Upside: +16.15%
Alphatec Holdings
Jul 23, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $9.29
Upside: +61.46%
iRhythm Holdings
Jul 22, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $127.98
Upside: +25.02%
Cytek Biosciences
May 13, 2026
Rated: Buy
Price Target: $4 → $4.75
Current: $4.66
Upside: +1.93%
Establishment Labs Holdings
Feb 25, 2026
Rated: Buy
Price Target: $90
Current: $71.52
Upside: +25.84%
Glaukos
Jan 2, 2026
Maintained: Buy
Price Target: $115 → $145
Current: $184.89
Upside: -21.57%
Pacific Biosciences of California
Nov 10, 2025
Maintained: Buy
Price Target: $2.5 → $2
Current: $1.23
Upside: +62.60%
NeoGenomics
Sep 2, 2025
Maintained: Buy
Price Target: $18 → $11
Current: $16.53
Upside: -33.45%
Aug 4, 2025
Rated: Buy
Price Target: $156 → $110
Current: $213.24
Upside: n/a
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $70
Current: $20.73
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $15 → $18
Current: $46.99
Upside: n/a
May 18, 2023
Reiterated: Buy
Price Target: $65
Current: $63.87
Upside: n/a
May 8, 2023
Reiterated: Buy
Price Target: $41
Current: $32.93
Upside: n/a
Dec 16, 2022
Maintained: Buy
Price Target: n/a
Current: $324.84
Upside: n/a
May 24, 2022
Downgraded: Hold
Price Target: $3.1 → $1.25
Current: $4.30
Upside: n/a